Anti Malarial Injection/ Tablet is an artemisinin derivative for the treatment of complicated malaria when the patient is immobile and has developed complications. The Anti Malarial Injection/ Tablet, available under the brand name "RTsunate" contain artesunate 60 mg in one vial injection and 50 mg in oral tablet. Anti Malarial Injection/ Tablet is manufactured by Themis Medicare Ltd. Themis Medicare Ltd. Also manufactures a wide range of Pharmaceutical Ingredients and therapeutic formulations in the field of antituberculosis, antimalarials, cardiology, pain management, anti-infectives, haematinics, Health and Nutrition. The Anti Malarial Injection is given as IV first and once the patient is stable then oral tablet is initiated.
